hydrocortisone
Trade name: solu-cortef
Approved
Apr 27, 1955
Hydrocortisone valerate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester. It can be used as a medicine to treat itching, swelling, and other skin conditions. — Wikipedia
Clinical trial activity
193 trials · 229 clinical orgs · 30 marketing orgs
Earliest trial started Mar 1, 2003 (NCT00801957)
Timeline
1950s
- Apr 27, 1955
Earliest FDA Approval
- Apr 27, 1955
Pharmacia & Upjohn — NDA Secondary Org
1970s
- Mar 17, 1978
Sun Pharmaceuticals — NDA Secondary Org
- Mar 28, 1978
Abbott — Marketing Organization
- Mar 28, 1978
Hospira — Marketing Organization
1980s
- May 28, 1981
Baxalta — Marketing Organization
- May 28, 1981
Baxter — Marketing Organization
- Mar 31, 1982
PreCision Dermatology — NDA Secondary Org
- Mar 31, 1982
Bausch Health Companies — NDA Secondary Org
1990s
- Feb 28, 1997
Fougera — NDA Secondary Org
- Feb 28, 1997
Ani Pharmaceuticals — Marketing Organization
- Feb 28, 1997
Ani Pharmaceuticals — NDA Secondary Org
- Aug 12, 1998
ACP Nimble — Marketing Organization
- Aug 12, 1998
G & W Laboratories Inc. — Marketing Organization
- Aug 25, 1998
Taro Pharmaceuticals — Marketing Organization
2000s
- May 24, 2000
Padagis Us — Marketing Organization
- May 24, 2000
Perrigo — Marketing Organization
- Jul 31, 2001
Fougera — Marketing Organization
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
2010s
- Jan 1, 2012
Earliest Phase 3 Sponsor(trial)
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
- Nov 21, 2017
Pharmaceutical Associates — Marketing Organization
- Nov 21, 2017
Teligent Pharmaceuticals — Marketing Organization
- Nov 21, 2017
THE J MOLNER — Marketing Organization
- Dec 8, 2017
Actavis — Marketing Organization
- Dec 8, 2017
Allergan PLC (2015) — Marketing Organization
- Oct 12, 2018
Glenmark Pharmaceuticals — Marketing Organization
- Aug 15, 2019
Lupin — Marketing Organization
2020s
- Mar 4, 2020
Cosette — Marketing Organization
- Nov 4, 2021
Encube Ethicals Pvt. Ltd. — Marketing Organization
- Sep 5, 2024
Cipla — Marketing Organization
Indications
Approved for
- Adrenal Hyperplasia, Congenital (approved 1952)
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid (approved 1952)
- Asthma
- Bursitis
- Colitis, Ulcerative
- Conjunctivitis, Allergic
- Crohn Disease
- Dermatitis
- Dermatitis, Atopic
- Dermatitis, Seborrheic
- Endocrine System Diseases
- Exanthema
- Herpes Labialis
- Inflammation
- Leukemia (approved 1952)
- Lymphoma
- Neoplasms
- Osteoarthritis
- Otitis Externa
- Pneumonia
- Pruritus
- Psoriasis
- Serum Sickness
- Skin Diseases
- Spondylitis
- Tenosynovitis
Studied for
- Addison Disease · Phase 4
- Adrenal Cortex Hormones · Phase 2
- Adrenal Gland Diseases · Phase 1/Phase 2
- Adrenal Gland Neoplasms · Phase 1/Phase 2
- Adrenal Hyperplasia, Congenital · Phase 4
- Adrenal Insufficiency · Phase 4
- Adrenocortical Hyperfunction · Phase 1/Phase 2
- Adult · Phase 2/Phase 3
- Alcohol Drinking · Early Phase 1
- Allografts · Phase 3
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis · Phase 4
- Arthritis, Rheumatoid · Phase 4
- Asphyxia · Phase 4
- Atrial Fibrillation · Phase 2/Phase 3
- Blood Pressure · Early Phase 1
- Borderline Personality Disorder · Phase 4
- Breast Neoplasms · Phase 4
- Burkitt Lymphoma · Phase 2
- Cannabis · Early Phase 1
- Carcinoma, Giant Cell · Phase 4
- Cigarette Smoking · Phase 1
- Cocaine-Related Disorders · Early Phase 1
- Colitis · Phase 1/Phase 2
- Community-Acquired Infections · Phase 4
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities · Phase 1/Phase 2
- COVID-19 · Phase 3
- Critical Illness · Phase 2/Phase 3
- Cyclosteroids · Phase 3
- Deficiency Diseases · Phase 4
- Depression · Phase 4
- Dermatitis · Phase 4
- Dermatology · Phase 2
- Diabetes Mellitus, Type 1 · Phase 2
- Disorders of Sex Development · Phase 1/Phase 2
- Down Syndrome · Phase 2
- Drinking Behavior · Early Phase 1
- Drug-Related Side Effects and Adverse Reactions · Phase 2
- Drugs, Investigational · Phase 4
- Dry Eye Syndromes · Phase 4
- Ductus Arteriosus, Patent · Phase 4
- Eczema · Phase 4
- Eye, Artificial · Phase 3
- Fasciitis, Plantar · Phase 1
- Fasting · Phase 4
- Fibrosis · Phase 4
- Genetic Diseases, Inborn · Phase 1/Phase 2
- Giant Cell Arteritis · Phase 4
- Glomerulonephritis · Phase 4
- Glucocorticoids · Early Phase 1
- Granuloma, Pyogenic · Phase 2/Phase 3
- Granulomatous Mastitis · Phase 4
- Healthy Volunteers · Phase 4
- Heart Rate · Early Phase 1
- Hematologic Neoplasms · Phase 1
- Hemorrhage · Phase 4
- Hemorrhoids · Phase 3
- HIV · Early Phase 1
- Hodgkin Disease · Phase 1
- Hydrocortisone · Phase 4
- Hyperglycemia · Phase 4
- Hypernatremia · Phase 2
- Hyperplasia · Phase 1/Phase 2
- Hypotension · Phase 4
- Hypoxia · Phase 3
- Hypoxia-Ischemia, Brain · Phase 4
- Immunoglobulin G4-Related Disease · Phase 3
- Immunosuppressive Agents · Phase 4
- Infections · Phase 2
- Inflammation · Phase 3
- Influenza, Human · Phase 1/Phase 2
- Intertrigo · Phase 4
- Intestinal Perforation · Phase 4
- Kidney Diseases · Phase 3
- Kidney Transplantation · Phase 4
- Leukemia · Phase 2
- Leukemia, Lymphoid · Phase 1
- Leukemia, Myeloid · Phase 2
- Leukemia, Myeloid, Acute · Phase 3
- Leukemia, Myelomonocytic, Juvenile · Phase 1
- Leukemia, T-Cell · Phase 1
- Lipomatosis, Multiple Symmetrical · Phase 3
- Low Back Pain · Phase 3
- Lumbar Vertebrae · Phase 4
- Lung Diseases · Phase 4
- Lupus Erythematosus, Systemic · Phase 4
- Lupus Nephritis · Phase 4
- Lymphoma · Phase 2
- Lymphoma, B-Cell · Phase 1
- Lymphoma, Large-Cell, Immunoblastic · Phase 2/Phase 3
- Lymphoma, T-Cell · Phase 2
- Medulloblastoma · Early Phase 1
- Meibomian Gland Dysfunction · Phase 4
- Memory, Episodic · Early Phase 1
- Memory, Long-Term · Early Phase 1
- Metabolic Diseases · Phase 2/Phase 3
- Muscle Weakness · Phase 2
- Muscular Dystrophies, Limb-Girdle · Phase 3
- Myelodysplastic Syndromes · Phase 1
- Neonatal Sepsis · Phase 4
- Neoplasm Metastasis · Phase 4
- Neoplasms · Phase 2
- Neoplasms, Germ Cell and Embryonal · Early Phase 1
- Neuroblastoma · Phase 1/Phase 2
- Neuroectodermal Tumors, Primitive · Early Phase 1
- Opioid-Related Disorders · Phase 2
- Osteoarthritis, Knee · Phase 4
- Pain · Phase 4
- Pancreatitis · Phase 2
- Pinealoma · Early Phase 1
- Polymyalgia Rheumatica · Phase 4
- Post-Cardiac Arrest Syndrome · Phase 3
- Post-Dural Puncture Headache · Phase 4
- Postoperative Complications · Phase 4
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma · Phase 2/Phase 3
- Precursor Cell Lymphoblastic Leukemia-Lymphoma · Phase 4
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma · Phase 2
- Premature Birth · Phase 4
- Proctitis · Phase 3
- Prostatic Neoplasms · Phase 3
- Prostatic Neoplasms, Castration-Resistant · Phase 3
- Psoriasis · Phase 1
- Psychological Distress · Phase 4
- Pulmonary Disease, Chronic Obstructive · Phase 4
- Purpura, Thrombotic Thrombocytopenic · Phase 3
- Respiratory Distress Syndrome · Phase 4
- Rhabdoid Tumor · Early Phase 1
- Sepsis · Phase 4
- Severe Acute Respiratory Syndrome · Phase 1/Phase 2
- Shivering · Phase 4
- Shock · Phase 4
- Shock, Cardiogenic · Phase 3
- Shock, Septic · Phase 4
- Sleep Disorders, Intrinsic · Early Phase 1
- Spinal Injuries · Phase 3
- Steroid Metabolism, Inborn Errors · Phase 1/Phase 2
- Stress Disorders, Post-Traumatic · Phase 2
- Stress Disorders, Traumatic, Acute · Phase 2
- Tacrolimus · Phase 1/Phase 2
- Thoracic Surgery · Phase 3
- Traumatology · Phase 2
- Urogenital Abnormalities · Phase 1/Phase 2
- Vasoconstriction · Phase 1
- Vasoplegia · Phase 3
- Vitiligo · Phase 1/Phase 2
Mechanism of action
- Glucocorticoid receptorAGONIST
NR3C1 agonist
- Glucocorticoid receptorAGONIST
Glucocorticoid receptor agonist
Approved veterinary
Approval history
- approvedApr 27, 1955
Chemistry & pharmacology
SMILES
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O.O- Mol. weight
- 480.55 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHydrocortisone valerate ↗
- ChEMBLCHEMBL3989663 ↗
- NCATSFXJ67LWZ4S ↗
- ChEMBLCHEMBL1683 ↗
- ChEMBLCHEMBL1641 ↗
- ChEMBLCHEMBL1200953 ↗
- ChEMBLCHEMBL977 ↗
- ChEMBLCHEMBL1200495 ↗
- WikipediaTəsi ↗
- WikipediaHydrocortisone hemisuccinate ↗
- WikipediaCortisol ↗
- NCATSWI4X0X7BPJ ↗
- ChEMBLCHEMBL1200562 ↗
- ChEMBLCHEMBL389621 ↗
- ChEMBLCHEMBL2106309 ↗
Also known as
- acetasol hc
- acetasol hc
- acticort
- acticort
- acticort
- acyclovir mixture with hydrocortisone
- aeroseb-hc
- aeroseb-hc
- a-hydrocort
- a-hydrocort
- a-hyrocort
- ala-cort
- ala-cort
- ala-scalp
- ala-scalp
- alphaderm
- alphaderm
- alphaderm
- anflam
- anflam
- anucort-hc
- anucort-hc
- anugesic hc
- anusol hc
- anusol hc
- anusol-hc
- anusol-hc
- anusol plus hc
- anusol soothing relief
- balneol-hc
- balneol-hc
- barquinol hc
- beta-hc
- beta-hc
- calmurid hc
- calmurid hc
- canesten hc
- canesten hc
- canesten hc
- cetacort
- cetacort
- cetacort
- cipro hc
- cipro hc
- cobadex
- cobadex
- colifoam
- colifoam
- colifoam
- colocort
- colocort
- corlan
- corlan
- cor-oticin
- cor-oticin
- cort-dome
- cort-dome
- cortef
- cortef
- cortef acetate
- cortef acetate
- cortenem
- cortenema
- cortenema
- cortifoam
- cortifoam
- cortifoam
- cortisol
- cortisol
- cortisol
- cortisol
- cortisol
- cortisol 17-butyrate
- cortisol 21-acetate
- cortisol-21-(hydrogen succinate)
- cortisol 21-phosphate
- cortisol acetate
- cortisol cypionate
- cortisol hemisuccinate
- cortisol succinate
- cortisol succinate, sodium salt
- cortisporin
- cortril
- cortril
- cortucid
- daktacort
- daktacort
- daktacort hydrocort
- derma care hydrocort
- dermacort
- dermacort
- dermaspray demang
- dioderm
- dioderm
- dome-cort
- dome-cort
- econacort
- efcortelan p
- eldecort
- eldecort
- epicort
- epicort
- epifoam
- epifoam
- epifoam
- eurax-hc
- eurax-hydrocort
- evacort
- evacort
- exe-cort
- flexicort
- flexicort
- framycort
- framycort
- fucidin h
- genticin hc
- gentisone hc
- germoloids hc
- glycort
- glycort
- gppe ear susp
- gppe eye crm
- gppe foam aero
- gregoderm
- hc #1
- hc #1
- hc #4
- hc #4
- hc45
- hc45
- hc45 hydrocort
- h-cort
- h-cort
- hcss
- hemsol-hc
- hepacort plus
- hi-cor
- hi-cor
- hidrocortisona
- hidrocortisona
- hydracort
- hydrasson
- hydrocal
- hydrocortancyl
- hydrocort in calamine oily
- hydrocort in cetomacrogol for a
- hydrocort in wte soft paraf
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone
- hydrocortisone 17alpha-butyrate
- hydrocortisone 17-butyrate
- hydrocortisone 17-butyrate
- hydrocortisone 17-butyrate
- hydrocortisone 17-butyrate
- hydrocortisone-17-butyrate
- hydrocortisone 17-butyrate 21-propionate
- hydrocortisone 21-acetate
- hydrocortisone 21-cyclopentylpropionate
- hydrocortisone 21-hemisuccinate sodium salt
- hydrocortisone 21-phosphate
- hydrocortisone 21-sodium succinate
- hydrocortisone aceponate
- hydrocortisone aceponate
- hydrocortisone aceponate
- hydrocortisone aceponate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate
- hydrocortisone acetate, (11alpha)-isomer
- hydrocortisone acetate, (11beta,17alpha)-isomer
- hydrocortisone acetate, (11beta)-isomer
- hydrocortisone acetate, monoammonium salt, (11beta)-isomer
- hydrocortisone acetate, sodium salt
- hydrocortisone buteprate
- hydrocortisone buteprate
- hydrocortisone buteprate
- hydrocortisone buteprate
- hydrocortisone butyrate
- hydrocortisone butyrate
- hydrocortisone butyrate
- hydrocortisone butyrate
- hydrocortisone butyrate
- hydrocortisone butyrate
- hydrocortisone butyrate
- hydrocortisone butyrate propionate
- hydrocortisone butyrate propionate
- hydrocortisone cipionate
- hydrocortisone cipionate
- hydrocortisone cyclopentylpropionate
- hydrocortisone cyclopentylpropionate
- hydrocortisone cyclopentylpropionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone cypionate
- hydrocortisone hemisuccinate
- hydrocortisone hemisuccinate
- hydrocortisone hemisuccinate
- hydrocortisone hemisuccinate
- hydrocortisone hemisuccinate
- hydrocortisone in absorbase
- hydrocortisone in absorbase
- hydrocortisone - neomycin - polymyxin b
- hydrocortisone, neomycin, polymyxin b drug combination
- hydrocortisone - oxytetracycline
- hydrocortisone, oxytetracycline drug combination
- hydrocortisone pentanoate
- hydrocortisone phosphate
- hydrocortisone phosphate
- hydrocortisone phosphate
- hydrocortisone phosphoric acid
- hydrocortisone probutate
- hydrocortisone probutate
- hydrocortisone probutate
- hydrocortisone probutate
- hydrocortisone probutate
- hydrocortisone sodium phosphate
- hydrocortisone sodium phosphate
- hydrocortisone sodium phosphate
- hydrocortisone sodium phosphate
- hydrocortisone sodium succinate
- hydrocortisone sodium succinate
- hydrocortisone sodium succinate
- hydrocortisone sodium succinate
- hydrocortisone sodium succinate
- hydrocortisone sodium succinate
- hydrocortisone succinate
- hydrocortisone succinate
- hydrocortisone succinate
- hydrocortisone succinate
- hydrocortisone succinate
- hydrocortisone - urea
- hydrocortisone, urea drug combination
- hydrocortisone valerate
- hydrocortisone valerate
- hydrocortisone valerate
- hydrocortisone valerate
- hydrocortisone valerate
- hydrocortisone valerate
- hydrocortisone valerate
- hydrocortisonum
- hydrocortisonum
- hydrocortisyl
- hydrocortone
- hydrocortone
- hydrocortone
- hydroderm
- hydroderm hc
- hydrodexan
- hydromol intensive
- hydro-rx
- hydro-rx
- hydroxycorticosterone acetate
- hytone
- hytone
- jungle for
- laticort
- locoid
- locoid
- locoid
- locoid
- locoid c
- locoid c
- locoid crelo
- locoid lipocream
- medicort
- medicort
- micort-hc
- mildison lipocream
- neo-cortef
- neo-cortef
- nogenic hc
- nogenic hc
- nsc-7576
- nsc-7576
- nutracort
- nutracort
- nybadex
- nystaform-hc
- nystaform-hc
- ophthocort
- ophthocort
- otoseptil
- otosporin
- otosporin
- otosporin
- pandel
- pandel
- pandel
- pandel
- penecort
- penecort
- perinal
- plenadren
- plenadren
- plenadren
- pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, (11beta)-
- proctocort
- proctocort
- proctocream hc
- proctofoam hc
- proctofoam hc
- proctosedyl
- proctosedyl
- quinocort
- sential hc
- solu-cortef
- solu-cortef
- solu-cortef
- solu-cortef
- sopolcort h
- sopolkort
- stie-cort
- stie-cort
- synacort
- synacort
- terracortril
- terra-cortril
- terra-cortril
- terra-cortril
- terra-cortril nystatin
- tesi
- texacort
- texacort
- timocort
- timocort
- timodine
- timodine
- topisone
- tri-cicatrin
- u-cort
- uniroid
- uniroid hc
- westcort
- westcort
- westcort
- xyloproct
- zenoxone
- zenoxone
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07175415 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2026 | AbbVie, AstraZeneca, Humboldt University, Princess Maxima Center for Pediatric Oncology |
| NCT07072585 | Phase 2/Phase 3 (Phase 3) | Mar 30, 2026 | National Cancer Institute (NCI) |
| NCT06881927 | Phase 4 | Feb 1, 2026 | University of Strasbourg |
| NCT07304739 | Phase 2 | Dec 22, 2025 | Tianjin Medical University |
| NCT06942039 | Early Phase 1 (Phase 1) | Sep 30, 2025 | C17 Council |
| NCT07190196 | Phase 3 | Sep 26, 2025 | Sanofi |
| NCT07124650 | Phase 4 | Sep 15, 2025 | Saint-Petersburg State Medical University |
| NCT07037043 | Phase 3 | Aug 31, 2025 | Rouen Normandy University, University of Lille, University of Picardie Jules Verne |
| NCT06892197 | Phase 4 | Aug 1, 2025 | University of Copenhagen |
| NCT06892210 | Phase 4 | Aug 1, 2025 | University of Copenhagen |
| NCT06982183 | Phase 4 | May 27, 2025 | United States Army |
| NCT06895473 | Phase 2 | Apr 1, 2025 | American Society of Clinical Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University |
| NCT06247787 | Phase 1 | Mar 28, 2025 | Geron Corporation, National Cancer Institute (NCI) |
| NCT07248761 | Phase 4 | Feb 1, 2025 | Government of Mexico, Instituto Mexicano del Seguro Social |
| NCT06317662 | Phase 2 | Jan 26, 2025 | National Cancer Institute (NCI) |
| NCT06390319 | Phase 2 | Dec 31, 2024 | AbbVie, St. Jude Children's Hospital |
| NCT06289673 | Phase 4 | Dec 31, 2024 | St. Jude Children's Hospital |
| NCT06504160 | Phase 2 | Dec 15, 2024 | National Institute of Allergy and Infectious Diseases (NIAID), National Jewish Health, Rho, Inc., University of California, San Diego |
| NCT06654596 | N/A | Nov 30, 2024 | Fudan University, Jiao Tong University, Second Military Medical University, Shanghai Longhua Hospital, Sichuan University, Wannan Medical College, Wuhan University, Yijishan Hospital of Wannan Medical College |
| NCT07154849 | Phase 4 | Nov 11, 2024 | Ain Shams University |
Organizations
Research & Development (229)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 10 | 8 | 3 | 2018 |
| Diurnal Limited | For profit | 7 | 7 | 3 | 2017 |
| St. Jude Children's Hospital | Academic/Hospital | 7 | 7 | 3 | 2019 |
| AbbVie | For profit | 6 | 1 | 2 | 2021 |
| Humboldt University | Academic/Hospital | 5 | 2 | 2 | 2014 |
| Innovative Therapies For Children with Cancer Consortium | Academic/Hospital | 5 | 0 | 1 | 2018 |
| National Institutes of Health (NIH) | Government | 5 | 0 | 2 | 2018 |
| Princess Maxima Center for Pediatric Oncology | Academic/Hospital | 5 | 5 | 1 | 2023 |
| University of Copenhagen | Academic/Hospital | 5 | 4 | 2 | 2016 |
| Wayne State University | Academic/Hospital | 5 | 4 | 2 | 2016 |
| Ain Shams University | Academic/Hospital | 4 | 4 | 2 | 2018 |
| Fight Kids Cancer | Academic/Hospital | 4 | 0 | 1 | 2023 |
| Harvard University | Academic/Hospital | 4 | 3 | 3 | 2018 |
| Merck | For profit | 4 | 4 | 2 | 2023 |
| National Institute on Drug Abuse (NIDA) | Government | 4 | 0 | 1 | 2016 |
| AVM Biotechnology LLC | For profit | 3 | 3 | 2 | 2020 |
| Brush Clinical Research Ltd. | For profit | 3 | 0 | 1 | 2017 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 2 | 2 | 2019 |
| Emas Pharma Ltd. | For profit | 3 | 0 | 1 | 2017 |
| Fudan University | Academic/Hospital | 3 | 2 | 2 | 2023 |
Marketing (39)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| ACP Nimble | For profit | MKTG | Aug 12, 1998 |
| Abbott | For profit | MKTG | Mar 28, 1978 |
| Abraxis | For profit | MKTG | — |
| Actavis | For profit | MKTG | Dec 8, 2017 |
| Allergan PLC (2015) | For profit | MKTG | Dec 8, 2017 |
| Ani Pharmaceuticals | For profit | MKTG | Feb 28, 1997 |
| Ani Pharmaceuticals | For profit | NDA2 | Feb 28, 1997 |
| Bausch Health Companies | For profit | NDA2 | Mar 31, 1982 |
| Baxalta | For profit | MKTG | May 28, 1981 |
| Baxter | For profit | MKTG | May 28, 1981 |
| Cipla | For profit | MKTG | Sep 5, 2024 |
| Cosette | For profit | SYN | Mar 4, 2020 |
| Cosette | For profit | MKTG | Mar 4, 2020 |
| Encube Ethicals Pvt. Ltd. | For profit | MKTG | Nov 4, 2021 |
| Fougera | For profit | NDA2 | Feb 28, 1997 |
| Fougera | For profit | MKTG | Jul 31, 2001 |
| G & W Laboratories Inc. | For profit | MKTG | Aug 12, 1998 |
| Glenmark Pharmaceuticals | For profit | MKTG | Oct 12, 2018 |
| Glenmark Pharmaceuticals | For profit | SYN | Sep 27, 2013 |
| Hospira | For profit | MKTG | Mar 28, 1978 |
| International Medication | For profit | MKTG | — |
| Lupin | For profit | MKTG | Aug 15, 2019 |
| Padagis Us | For profit | MKTG | May 24, 2000 |
| Perrigo | For profit | SYN | May 24, 2000 |
| Perrigo | For profit | MKTG | May 24, 2000 |
| Pharmaceutical Associates | For profit | MKTG | Nov 21, 2017 |
| Pharmacia & Upjohn | For profit | NDA2 | Apr 27, 1955 |
| PreCision Dermatology | For profit | NDA2 | Mar 31, 1982 |
| Sun Pharmaceuticals | For profit | NDA2 | Mar 17, 1978 |
| Sun Pharmaceuticals | For profit | SYN | Mar 17, 1978 |
| THE J MOLNER | For profit | MKTG | Nov 21, 2017 |
| Taro Pharmaceuticals | For profit | SYN | Jan 14, 2004 |
| Taro Pharmaceuticals | For profit | SYN | Dec 27, 2004 |
| Taro Pharmaceuticals | For profit | MKTG | Aug 25, 1998 |
| Teligent Pharmaceuticals | For profit | MKTG | Nov 21, 2017 |
| Teligent Pharmaceuticals | For profit | SYN | Nov 21, 2017 |
| Upjohn | For profit | NDA | — |
| Watson Pharmaceuticals | For profit | MKTG | — |
| Yamanouchi Pharmaceuticals | For profit | NDA2 | — |